-
1 Comment
Tong Ren Tang Technologies Co. Ltd is currently in a long term uptrend where the price is trading 20.4% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.2.
Finally, its free cash flow fell by 23.5% to $177M since the same quarter in the previous year.
Based on the above factors, Tong Ren Tang Technologies Co. Ltd gets an overall score of 2/5.
Industry | Drug Manufacturers-General |
---|---|
ISIN | CNE100000585 |
CurrencyCode | EUR |
Exchange | F |
Sector | Healthcare |
PE Ratio | 17.3 |
---|---|
Target Price | None |
Dividend Yield | 2.8% |
Market Cap | 1B |
Beta | 0.89 |
Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for TNG.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024